Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-503
Closed -$3.24K 2481
2024
Q3
$3.24K Sell
503
-808
-62% -$5.3K ﹤0.01% 2485
2024
Q2
$13.8K Buy
+1,311
New +$10.4K ﹤0.01% 1815
2024
Q1
Sell
-206
Closed -$2K 2204
2023
Q4
$2K Buy
+206
New +$1.57K ﹤0.01% 2095
2023
Q3
Sell
-14
Closed 2029
2023
Q2
$0 Sell
14
-435
-97% -$4.12K ﹤0.01% 2029
2023
Q1
$4K Sell
449
-152
-25% -$1.23K ﹤0.01% 1819
2022
Q4
$6K Buy
601
+565
+1,569% +$6.28K ﹤0.01% 1654
2022
Q3
$1K Buy
+36
New +$450 ﹤0.01% 1881

Other funds holding BAK

Blue Trust Inc's BAK Position: Q4 2024 in Review

Blue Trust Inc sold out of Braskem (BAK) in Q4 2024, closing a stake of 503 shares — an estimated $3.24K sold.

Blue Trust Inc first reported a position in BAK in Q3 2022 and held it in 7 quarters. The position peaked at $13.8K in Q2 2024. 60 funds tracked by Wall St. Rank hold BAK as of Q4 2024.

  • Blue Trust Inc reported no remaining Braskem position as of Q4 2024 after selling out during the quarter.
  • Blue Trust Inc sold 503 Braskem shares in Q4 2024, an estimated $3.24K.
  • Blue Trust Inc first reported a position in Braskem in Q3 2022 and held it in 7 quarters.
  • Blue Trust Inc's Braskem position peaked at $13.8K in Q2 2024.
  • 60 funds tracked by Wall St. Rank held Braskem as of Q4 2024.

Based on Blue Trust Inc's 13F filing for Q4 2024, filed 22 Jan 2025.